Webinar: Microfluidics Innovations in Diagnostics and Cancer Care
Join us for this exclusive webinar with Dr. Mehmet Toner, a leading expert in biomedical engineering and a pioneer in microfluidics. With over 200 publications, Dr. Toner has advanced cancer diagnostics and personalized medicine through innovations in circulating tumor cells and microfluidic technologies.
Date: April 7th, 2025:
4:00 PM CEST (Paris) / 3:00 PM BST (London) / 10:00 AM EDT (New York-Montreal)
Speaker:
Dr. Mehmet Toner – Professor of Surgery and Biomedical Engineering – Harvard Medical School and Massachusetts General Hospital
Hosted by Dr. Joseph Farah – Microfluidic Application Engineer – Fluigent
Agenda:
- Circulating Tumor Cells (CTC): Innovations in tumor cell sorting and circulation, transforming diagnostics and personalized cancer care.
- Recent Microfluidics Developments: Latest advancements in microfluidics, including the microfluidic transistor’s impact on fluid control and biomedical applications.
- Q&A with Dr. Mehmet Toner: Interactive session with Dr.Toner, offering insights into the future of microfluidics and answering your questions during the webinar.
Can’t make it live? Sign up and watch the replay for free.
About the Speaker:
Dr. Mehmet Toner is a distinguished Professor of Biomedical Engineering at Massachusetts General Hospital and Harvard Medical School, with a joint appointment at the Harvard-MIT Division of Health Sciences and Technology. A pioneer in microfluidics and BioMEMS, Dr. Toner has revolutionized the integration of living cells with micro-engineered devices, advancing blood processing technologies and cancer diagnostics, particularly through his groundbreaking work on circulating tumor cell sorting.
He is the Founder of the NIH BioMEMS Resource Center and Co-founder of the Center for Engineering in Medicine & Surgery, influencing global health diagnostics and personalized medicine.
Internationally recognized for his multidisciplinary approach at the intersection of engineering and life sciences, Dr. Toner has authored over 200 papers. His most recent research focuses on microfluidic transistors, cell circulation mechanisms, and the development of microfluidic platforms for clinical medicine. His work is paving the way for next-generation diagnostics and therapeutic strategies.
